Struggling genetic testing 23andMe is looking for a buyer for the virtual care business it acquired in 2021, Business Insider ...

Investing.com -- Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to Business Insider. The company, which has faced financial ...

The struggling health company bought virtual care startup Lemonaid in 2021 for $400 million. 23andMe's stock has plummeted after a 2023 data breach exposed millions of customer accounts.

The struggling health company bought virtual care startup Lemonaid in 2021 for $400 million. 23andMe's stock has plummeted after a 2023 data breach exposed millions of customer accounts. Struggling ...

Me still merchandises its ancestry, health analysis, and the Total Health annual package on a scale from $99 to $999 annually. Lemonaid entered the hot GLP-1 prescribing and support business in 2024, ...

Me (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider.Stay Ahead of the ...